9B2 Stock Overview
Manufactures and distributes surfactants in Poland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
PCC Exol S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.56 |
| 52 Week High | zł0.71 |
| 52 Week Low | zł0.55 |
| Beta | 1.38 |
| 11 Month Change | -7.01% |
| 3 Month Change | -7.48% |
| 1 Year Change | -15.86% |
| 33 Year Change | -4.21% |
| 5 Year Change | n/a |
| Change since IPO | -20.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9B2 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -4.0% | -0.1% | 0.8% |
| 1Y | -15.9% | 0.1% | 9.1% |
Return vs Industry: 9B2 underperformed the German Chemicals industry which returned -0.3% over the past year.
Return vs Market: 9B2 underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| 9B2 volatility | |
|---|---|
| 9B2 Average Weekly Movement | 3.4% |
| Chemicals Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9B2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 9B2's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 323 | Dariusz Ciesielski | www.pcc-exol.eu |
PCC Exol S.A. manufactures and distributes surfactants in Poland and internationally. The company provides anionic and nonionic surfactants. It primarily serves household and industrial chemical, textile, plastic, industrial cleaning, metal working, and other industries.
PCC Exol S.A. Fundamentals Summary
| 9B2 fundamental statistics | |
|---|---|
| Market cap | €99.81m |
| Earnings (TTM) | €6.41m |
| Revenue (TTM) | €212.50m |
15.6x
P/E Ratio0.5x
P/S RatioIs 9B2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9B2 income statement (TTM) | |
|---|---|
| Revenue | zł915.71m |
| Cost of Revenue | zł760.12m |
| Gross Profit | zł155.59m |
| Other Expenses | zł127.96m |
| Earnings | zł27.63m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 16.99% |
| Net Profit Margin | 3.02% |
| Debt/Equity Ratio | 60.3% |
How did 9B2 perform over the long term?
See historical performance and comparison